Gaois

Search direction

Search mode

Filter results

Collections

1,270 results in 86 documents

  1. #2768410

    ciallaíonn “táirge íocshláinte frithmhiocróbach” táirge íocshláinte ina bhfuil ábhar frithmhiocróbach amháin nó níos mó;

    ‘antimicrobial medicinal product’ means a medicinal product that contains or consists of one or more antimicrobials;

    Commission Delegated Regulation (EU) 2023/905 of 27 February 2023 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union (Text with EEA relevance)

  2. #640808

    Ciallaíonn “táirge íocshláinte cúnta” táirge íocshláinte a úsáidtear le haghaidh riachtanais trialach cliniciúla de réir mar a bhfuil tuairisc air sin sa phrótacal, ach nach n-úsáidtear mar tháirge íocshláinte imscrúdaithe;

    ‘Auxiliary medicinal product’ means a medicinal product used for the needs of a clinical trial as described in the protocol, but not as an investigational medicinal product;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  3. #640809

    Ciallaíonn “táirge íocshláinte imscrúdaitheach údaraithe” táirge íocshláinte atá údaraithe i gcomhréir le Rialachán (CE) Uimh.726/2004, nó, in aon cheann de na Ballstáit lena mbaineann, i gcomhréir le Treoir 2001/83/CE, beag beann ar athruithe ar lipéadú an táirge íocshláinte, a úsáidtear mar tháirge íocshláinte imscrúdaitheach;

    ‘Authorised investigational medicinal product’ means a medicinal product authorised in accordance with Regulation (EC) No 726/2004 or in any Member State concerned in accordance with Directive 2001/83/EC, irrespective of changes to the labelling of the medicinal product, which is used as an investigational medicinal product;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  4. #640810

    Ciallaíonn “táirge íocshláinte cúnta údaraithe” táirge íocshláinte atá údaraithe i gcomhréir le Rialachán (CE) Uimh.726/2004, nó, in aon cheann de na Ballstáit lena mbaineann, i gcomhréir le Treoir 2001/83/CE, beag beann ar athruithe ar lipéadú an táirge íocshláinte, a úsáidtear mar tháirge íocshláinte cúnta;

    ‘Authorised auxiliary medicinal product’ means a medicinal product authorised in accordance with Regulation (EC) No 726/2004, or in any Member State concerned in accordance with Directive 2001/83/EC, irrespective of changes to the labelling of the medicinal product, which is used as an auxiliary medicinal product;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  5. #1733782

    ciallaíonn “táirge íocshláinte tréidliachta cineálach” táirge íocshláinte tréidliachta a bhfuil an comhdhéanamh céanna cáilíochtúil agus cainníochtúil de shubstaintí gníomhacha ann agus an fhoirm chógaisíochta chéanna ann agus atá sa táirge íocshláinte tréidliachta tagartha, agus inar léiríodh bithchoibhéis leis an táirge íocshláinte tréidliachta tagartha;

    ‘generic veterinary medicinal product’ means a veterinary medicinal product which has the same qualitative and quantitative composition of active substances and the same pharmaceutical form as the reference veterinary medicinal product, and with regard to which bioequivalence with the reference veterinary medicinal product has been demonstrated;

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  6. #1733977

    I gcás nach n-údaraítear an táirge íocshláinte tréidliachta tagartha sa Bhallstát ina gcuirtear isteach an t-iarratas don táirge íocshláinte tréidliachta cineálach, nó ina gcuirtear isteach an t-iarratas i gcomhréir le hAirteagal 42(4) agus ina n-údaraítear an táirge íocshláinte tréidliachta tagartha i mBallstát, cuirfidh an t-iarratasóir an Ballstát inar údaraíodh an táirge íocshláinte tréidliachta tagartha in iúl ina iarratas.

    Where the reference veterinary medicinal product is not authorised in the Member State in which the application for the generic veterinary medicinal product is submitted, or the application is submitted in accordance with Article 42(4) and the reference veterinary medicinal product is authorised in a Member State, the applicant shall indicate in its application the Member State in which the reference veterinary medicinal product has been authorised.

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  7. #284900

    (a) Ciallaíonn "táirge íocshláinte ardteiripe" aon cheann de na táirgí seo a leanas ar táirgí lena n-úsáid ag an duine iad:

    (a) "Advanced therapy medicinal product" means any of the following medicinal products for human use:

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  8. #284915

    (d) Ciallaíonn "táirge íocshláinte ardteiripe" táirge íocshláinte ardteiripe a chomhlíonfaidh na coinníollacha seo a leanas:

    (d) "Combined advanced therapy medicinal product" means an advanced therapy medicinal product that fulfils the following conditions:

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  9. #284923

    - ar tháirge íocshláinte theiripe na gceall sómach nó ar tháirge a ndearnadh innealtóireacht fhíocháin air, agus

    - a somatic cell therapy medicinal product or a tissue engineered product, and

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  10. #284924

    - ar tháirge íocshláinte géinteiripe

    - a gene therapy medicinal product,

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  11. #284925

    measfar gur táirge íocshláinte géinteiripe é.

    shall be considered as a gene therapy medicinal product.

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  12. #285097

    Táirge íocshláinte ardteiripe:

    Advanced therapy medicinal product:

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  13. #285147

    1. Ainm an táirge íocshláinte.

    1. Name of the medicinal product.

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  14. #285189

    (g) Aon rabhadh speisialta is gá don táirge íocshláinte áirithe sin;

    (g) Any special warning necessary for the particular medicinal product;

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  15. #285200

    (a) Chun an táirge íocshláinte ardteiripe a aithint:

    (a) For the identification of the advanced therapy medicinal product:

    Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004

  16. #346458

    ciallaíonn "táirge" an comhábhar gníomhach nó teaglaim de chomhábhair ghníomhacha i dtáirge íocshláinte;

    "product" means the active ingredient or combination of active ingredients of a medicinal product;

    Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products

  17. #346577

    maidir le haon táirge íocshláinte a chosnaítear le paitinn bhunúsach bhailí i bPoblacht na Seice agus dá bhfuarthas an chéad údarú chun é a chur ar an margadh mar tháirge íocshláinte:

    any medicinal product protected by a valid basic patent in the Czech Republic and for which the first authorisation to place it on the market as a medicinal product was obtained:

    Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products

  18. #563347

    aon táirge míochaine bitheolaíoch nach bhfuil cumhdaithe faoi phointe (a) agus a údaraíodh tar éis an 1 Eanáir 2011;

    any biological medicinal product not covered by point (a) that was authorised after 1 January 2011;

    Regulation (EU) No 1027/2012 of the European Parliament and of the Council of 25 October 2012 amending Regulation (EC) No 726/2004 as regards pharmacovigilance Text with EEA relevance

  19. #640592

    an táirge íocshláinte imscrúdaithigh agus an idirghabháil.

    the investigational medicinal product and the intervention.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  20. #640805

    Ciallaíonn “táirge íocshláinte imscrúdaitheach” táirge íocshláinte a ndéantar a thástáil nó a úsáid mar thagairt, lena n-áirítear mar phlacebo, i dtriail chliniciúil;

    ‘Investigational medicinal product’ means a medicinal product which is being tested or used as a reference, including as a placebo, in a clinical trial;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  21. #640807

    Ciallaíonn “táirge íocshláinte imscrúdaitheach ardteiripe” táirge íocshláinte imscrúdaitheach ar táirge íocshláinte ardteiripe é mar atá sainmhínithe i bpointe (a) d'Airteagal 2(1) de Rialachán (CE) Uimh.1394/2007 ó Pharlaimint na hEorpa agus ón gComhairle(11);

    ‘Advanced therapy investigational medicinal product’ means an investigational medicinal product which is an advanced therapy medicinal product as defined in point (a) of Article 2(1) of Regulation (EC) No 1394/2007 of the European Parliament and of the Council(11);

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  22. #641417

    Ní bheidh feidhm ag mír 1 i gcás nach mbeidh aon táirge íocshláinte cúnta údaraithe ar fáil san Aontas nó i gcás nach bhféadfar a bheith ag súil leis go réasúnta go n-úsáidfeadh an t-urraitheoir táirge íocshláinte cúnta údaraithe.

    Paragraph 1 shall not apply where no authorised auxiliary medicinal product is available in the Union or where the sponsor cannot reasonably be expected to use an authorised auxiliary medicinal product.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  23. #641464

    faisnéis lena sainaithnítear an táirge íocshláinte;

    information to identify the medicinal product;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  24. #641465

    faisnéis a bhaineann le húsáid an táirge íocshláinte.

    information related to the use of the medicinal product.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  25. #641483

    Féadfar an táirge íocshláinte a lipéadú i roinnt teangacha.

    The medicinal product may be labelled in several languages.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  26. #641577

    Chuige sin, agus chomh maith chun a chumasú don urraitheoir crostagairt d'iarratais roimh ré, eiseofar uimhir táirge íocshláinte AE do gach táirge íocshláinte, gan údarú margaíochta agus eiseofar cód substaintí gníomhacha AE do gach substaint ghníomhach nach bhfuil údaraithe cheana mar chuid de tháirge íocshláinte san Aontas.

    To this effect and also with the purpose of enabling the sponsor to cross-refer to prior applications, an EU medicinal product number shall be issued for every medicinal product without a marketing authorisation and an EU active substances code shall be issued for each new active substance not previously authorised as part of a medicinal product in the Union.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  27. #641789

    tuairisc ar na socruithe chun an táirge íocshláinte imscrúdaitheach agus an táirge íocshláinte cúnta neamhúdaraithe a rianú, a stóráil, a scriosadh agus a chur ar ais i gcomhréir le hAirteagal 51;

    a description of the arrangements for tracing, storing, destroying and returning the investigational medicinal product and unauthorised auxiliary medicinal product in accordance with Article 51;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  28. #641842

    F.DOICIMÉADACHT A BHAINEANN LE DEA-CHLEACHTAS MONARAÍOCHTA (DCM) A CHOMHLÍONADH I NDÁIL LEIS AN TÁIRGE ÍOCSHLÁINTE IMSCRÚDAITHEACH

    F.DOCUMENTATION RELATING TO COMPLIANCE WITH GOOD MANUFACTURING PRACTICE (GMP) FOR THE INVESTIGATIONAL MEDICINAL PRODUCT

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  29. #641850

    G.SAINCHOMHAD AN TÁIRGE ÍOCSHLÁINTE IMSCRÚDAITHIGH (STMI)

    G.INVESTIGATIONAL MEDICINAL PRODUCT DOSSIER (IMPD)

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  30. #641852

    Sonraí a bhaineann leis an táirge íocshláinte imscrúdaitheach

    Data relating to the investigational medicinal product

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  31. #641908

    Níor údaraíodh an táirge íocshláinte imscrúdaitheach agus níl aon údarú margaíochta aige i dtír ICH ach tá an tsubstaint ghníomhach i dtáirge íocshláinte údaraithe agus

    The investigational medicinal product is not authorised and has no marketing authorisation in an ICH country but the active substance is contained in an authorised medicinal product, and

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  32. #641924

    H.SAINCHOMHAD TÁIRGE ÍOCSHLÁINTE CÚNTA

    H.AUXILIARY MEDICINAL PRODUCT DOSSIER

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  33. #642026

    táirge íocshláinte imscrúdaitheach amhrasta (lena n-áirítear ainmchód substainte gníomhaí);

    a suspect investigational medicinal product (including active substance name-code);

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  34. #642141

    ainm an táirge íocshláinte, agus ina dhiaidh sin an tiúchán agus foirm an chógais;

    name of the medicinal product, followed by its strength and pharmaceutical form;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  35. #744244

    feistí ina bhfuil táirge íocshláinte mar chuid dhílis díobh,

    devices that incorporate as an integral part a medicinal product,

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  36. #747375

    ina theannta sin, le haghaidh feiste dhiagnóiseach choimhdeachta, an spriocdhaonra ábhartha agus an táirge/na táirgí leighis lena mbaineann.

    in addition, for companion diagnostics, the relevant target population and the associated medicinal product(s).

    Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )

  37. #1525372

    ní fholaíonn “coimeádán” coimeádán le haghaidh aon táirge leigheasaigh;

    "container" does not include a container for any medicinal product;

    Number 2 of 1994: CRIMINAL JUSTICE (PUBLIC ORDER) ACT, 1994

  38. #1671567

    Níor cheart aon mheasúnú riosca a dhéanamh ar shubstaint shícighníomhach nua má tá sí ina substaint ghníomhach i dtáirge íocshláinte lena úsáid ag an duine nó i dtáirge íocshláinte tréidliachta.

    No risk assessment should be carried out on a new psychoactive substance if it is an active substance in a medicinal product for human use or in a veterinary medicinal product.

    Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances

  39. #1671597

    faisnéis maidir le húsáid mhíochaine na substainte sícighníomhaí nua sa duine agus sa tréidliacht, lena n-áirítear a húsáid mar shubstaint ghníomhach i dtáirge íocshláinte lena úsáid ag an duine nó i dtáirge íocshláinte tréidliachta;

    information on the human and veterinary medical use of the new psychoactive substance, including as an active substance in a medicinal product for human use or in a veterinary medicinal product;

    Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances

  40. #1671607

    táirge íocshláinte lena úsáid ag an duine nó i dtáirge íocshláinte tréidliachta atá ina ábhar d'iarratas ar údarú margaíochta;

    a medicinal product for human use or in a veterinary medicinal product that is the subject of an application for a marketing authorisation;

    Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances

  41. #1671608

    táirge íocshláinte lena úsáid ag an duine nó i dtáirge íocshláinte tréidliachta a bhfuil a údarú margaíochta curtha ar fionraí ag an údarás inniúil;

    a medicinal product for human use or in a veterinary medicinal product whose marketing authorisation has been suspended by the competent authority;

    Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances

  42. #1671648

    táirge íocshláinte lena úsáid ag an duine nó i dtáirge íocshláinte tréidliachta a bhfuil údarú margaíochta faighte aige;

    a medicinal product for human use or in a veterinary medicinal product that has obtained a marketing authorisation;

    Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances

  43. #1686144

    ciallaíonn “táirge míochaine tréidliachta” táirge míochaine tréidliachta mar a shainmhínítear i bpointe 2 d’Airteagal 1 de Threoir 2001/82/CE ó Pharlaimint na hEorpa agus ón gComhairle;

    ‘veterinary medicinal product’ means a veterinary medicinal product as defined in point (2) of Article 1 of Directive 2001/82/EC of the European Parliament and of the Council;

    Regulation (EU) 2018/848 of the European Parliament and of the Council of 30 May 2018 on organic production and labelling of organic products and repealing Council Regulation (EC) No 834/2007

  44. #1733115

    Dá thoradh sin, sa Rialachán seo, ciallaíonn ‘táirge íocshláinte’ agus ‘táirge íocshláinte lena n-úsáid ag an duine’ táirge íocshláinte amhail a shainmhínítear i bpointe (2) d’Airteagal 1 de Threoir 2001/83/CE;

    As a consequence, in this Regulation, the terms, “medicinal product” and “medicinal product for human use” mean a medicinal product as defined in point (2) of Article 1 of Directive 2001/83/EC.

    Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)

  45. #1733117

    ciallaíonn ‘táirge íocshláinte tréidliachta’ táirge íocshláinte a shainmhínítear i bpointe (1) d’Airteagal 4de Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle;

    “veterinary medicinal product” means a medicinal product as defined in point (1) of Article 4 of Regulation (EU) 2019/6 of the European Parliament and of the Council ;

    Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)

  46. #1733519

    Féadfaidh cásanna a bheith ann, áfach, nach mbeidh aon táirge íocshláinte tréidliachta atá údaraithe mar is iomchuí ar fáil.

    There may be, however, situations where no suitable authorised veterinary medicinal product is available.

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  47. #1733545

    Sonraí agus doiciméid áirithe atá le seoladh isteach le hiarratas ar údarú margaíochta de ghnáth, níor cheart gá a bheith leo más táirge íocshláinte cineálach de chuid táirge íocshláinte tréidliachta atá údaraithe nó a bhí údaraithe san Aontas atá sa táirge íocshláinte tréidliachta.

    Certain particulars and documents that are normally to be submitted with an application for a marketing authorisation should not be required if a veterinary medicinal product is a generic medicinal product of a veterinary medicinal product that is authorised or has been authorised in the Union.

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  48. #1733619

    Sa chás sin, ba cheart do gach saintréith a bhaineann leis an táirge íocshláinte tréidliachta agus na sonraí go léir atá mar thacaíocht leis an táirge íocshláinte tréidliachta a bheith díreach mar an gcéanna.

    In that case, all product-related characteristics of the veterinary medicinal product and data in support of the applications for the veterinary medicinal product should be identical.

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  49. #1733778

    ciallaíonn “táirge íocshláinte tréidliachta imdhíoneolaíoch” táirge íocshláinte tréidliachta atá beartaithe a thabhairt d’ainmhí chun imdhíonacht ghníomhach nó éighníomhach a tháirgeadh nó chun a riocht imdhíonachta a dhiagnóisiú;

    ‘immunological veterinary medicinal product’ means a veterinary medicinal product intended to be administered to an animal in order to produce active or passive immunity or to diagnose its state of immunity;

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

  50. #1733779

    ciallaíonn “táirge íocshláinte tréidliachta bitheolaíoch” táirge íocshláinte tréidliachta inar substaint bhitheolaíoch í an tsubstaint ghníomhach.

    ‘biological veterinary medicinal product’ means a veterinary medicinal product where an active substance is a biological substance;

    Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)